Visfatin as a modulator of factors involved in human placental invasion and angiogenesis: interactions with folic acid and aspirin
Reproduction, Fertility and Development · 2026
DOI: 10.1071/rd25160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, Fertility and Development, 2026. Verfasst von Monika Dawid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jagiellonian University, Faculty of Biology, Institute of Zoology and Biomedical Research, Laboratory of Physiology and Toxicology of Reproduction, K…. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, Folic Acid, Aspirin, Placenta.
Abstract (Originalsprache)
Context
Our previous studies demonstrated the expression of visfatin in the human placenta and its impact on placental cell proliferation and apoptosis. AIMS: This study aimed to examine the effect of visfatin, folic acid (FA), and aspirin (ASA) on markers of invasion and angiogenesis in the human placenta. METHODS: JEG-3 cells and placental villi from normal pregnancies at term were treated for 48 h with visfatin (1, 10 or 100 ng/mL) to asses the levels of metalloproteinases (MMP-2/MMP-9), their inhibitors (TIMP-1/TIMP-2), and vascular endothelial growth factors (VEGFA/PLGF). Next, using a pharmacological inhibitor of both the insulin receptor (INSR) and selected kinase pathways, the action of visfatin on the levels of MMPs, TIMPs, VEGFA, and PLGF was analyzed in JEG-3 cells. Finally, using the same research model, the effects of FA (2, 20, 100 nM) or ASA (0.1 mM) on visfatin and INSR expression, as well as the levels of the mentioned factors regulating invasion and angiogenesis, were studied. Key results: Visfatin increased MMP-9 levels, while decreasing MMP-2, TIMPs, VEGFA, and PLGF, through distinct intracellular pathways. FA reduced visfatin level and modulated INSR, while ASA decreased both. Moreover, the combined use of FA or ASA with visfatin altered the effect observed for visfatin alone.
Conclusions
Visfatin acts as a novel regulator of invasion factors and decreases the levels of agents involved in angiogenesis; FA or ASA can modulate its activity.
Implications
The regulatory potential of FA and ASA on visfatin action may be relevant in the context of pregnancy-related pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jagiellonian University, Faculty of Biology, Institute of Zoology and Biomedical Research, Laboratory of Physiology and Toxicology of Reproduction, Kraków, Poland.
- Jagiellonian University, Doctoral School of Exact and Natural Sciences, Kraków, Poland.
- Jagiellonian University Medical College, Faculty of Medicine, Department of Gynecological Endocrinology, Kraków, Poland.
ORCID-Profile: Monika Dawid, Agnieszka Rak
Zitieren
APA
Dawid, M., Milewicz, T., & Rak, A. (2026). Visfatin as a modulator of factors involved in human placental invasion and angiogenesis: interactions with folic acid and aspirin. Reproduction, Fertility and Development. https://doi.org/10.1071/rd25160
Vancouver
Dawid M, Milewicz T, Rak A. Visfatin as a modulator of factors involved in human placental invasion and angiogenesis: interactions with folic acid and aspirin. Reproduction, Fertility and Development. 2026. doi:10.1071/rd25160
BibTeX
@article{Dawid2026,
author = {Dawid, Monika and Milewicz, Tomasz and Rak, Agnieszka},
title = {Visfatin as a modulator of factors involved in human placental invasion and angiogenesis: interactions with folic acid and aspirin},
journal = {Reproduction, Fertility and Development},
year = {2026},
doi = {10.1071/rd25160}
}
EUVIMED